# Noetik

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/noetik

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.noetik.ai
- Total disclosed funding: $48M
- Latest round: Series A (Jul 31, 2024)
- Investors on record: 10

## About

Based in California, US, and founded in 2022, Noetik Inc. operates as a biotechnology company that develops an artificial intelligence-powered platform for cancer immunotherapy. The company was Co-founded by Ron Alfa and Jacob Rinaldi.In March 2026, Noetik Inc. raised USD 50 million in venture funding from GlaxoSmithKline Plc.

The company develops artificial intelligence-based cancer immunotherapies by using self-supervised learning and human multimodal data. The medical software offered by the firm uses various technologies to understand the traits of cancer and help in research for oncology treatment. The company will use the March 2026 funding to accelerate AI-driven cancer research.

## Funding rounds

- Series A, Jul 31, 2024, $40M — Polaris Partners
- Seed, Aug 30, 2022, $8M — EPIC Ventures, Hummingbird Ventures, DCVC, Zetta Venture Partners, 11.2 Capital, Intermountain Ventures, Catalio Capital Management, North South Ventures, CJNV BioVenture

## Investors

- EPIC Ventures (https://capitalatlas.ai/funds/epic-ventures) — Seed
- Hummingbird Ventures (https://capitalatlas.ai/funds/hummingbird-ventures) — Seed
- DCVC (https://capitalatlas.ai/funds/dcvc) — Seed
- Zetta Venture Partners (https://capitalatlas.ai/funds/zetta-venture-partners) — Seed
- 11.2 Capital (https://capitalatlas.ai/funds/11-2-capital) — Seed
- Intermountain Ventures (https://capitalatlas.ai/funds/intermountain-ventures) — Seed
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Seed
- North South Ventures (https://capitalatlas.ai/funds/north-south-ventures) — Seed
- CJNV BioVenture — Seed
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A